5O' Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell, 1997, 88 (2): 277-85.
6Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997, 390 (6 658): 404-7.
8Sasaki T, Larsson H, Kreuger J, et al. Structure basis and potential role of heparin/heparin sulfate binding to the angiogenesis inhibitor endostatin. EMBO J, 1999, 18:6 240-8.
9Ricard-Blum S, Ferand O, Lortat-Jacob H, et al. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling:role of divalent cations. J Biol Chem, 2004,279(4) :2 927-36.
10Hohenester E, Sasaki T, Olsen BR, et al. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J, 1998, 17 (6): 1 656-64.
